BI

BioInvent International ABSTO BioInvent Stock Report

Last reporting period 30 Sep, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.293

Micro

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

BioInvent Cash and equivalents

0.95 B

Last period Cash and equivalents ,SEK

405%

Cash and equivalents has increased in 5 years


What is Cash and equivalents ?

Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.

What is Cash and equivalents ?

Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.

What is Cash and equivalents of BioInvent ?

BioInvent`s Cash and equivalents for the period ended 2024-09-30 are 0.95 B SEK

View Full Company Analysis